4//SEC Filing
Walsh Deina H 4
Accession 0001493152-24-003099
CIK 0001419554other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:24 PM ET
Size
7.7 KB
Accession
0001493152-24-003099
Insider Transaction Report
Form 4
Walsh Deina H
Chief Financial Officer
Transactions
- Award
Employee Stock Option
2024-01-17+12,500→ 12,500 totalExercise: $3.61From: 2024-01-17Exp: 2026-01-17→ Common Stock (12,500 underlying)
Holdings
- 78
Employee Stock Option
Exercise: $57.60Exp: 2025-01-25→ Common Stock (78 underlying) - 1,875
Common Stock
Footnotes (2)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
- [F2]This option is fully vested as of the date of this report.
Documents
Issuer
Bone Biologics Corp
CIK 0001419554
Entity typeother
Related Parties
1- filerCIK 0001651572
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:24 PM ET
- Size
- 7.7 KB